Clinical Study

Overexpression of an Immune Checkpoint (CD155) in Breast Cancer Associated with Prognostic Significance and Exhausted Tumor-Infiltrating Lymphocytes: A Cohort Study

Figure 3

Relationship between Ki-67 index and CD155 status. (a) Ki-67 expression among patients with low expression of CD155. (b) Ki-67 expression among patients with overexpression of CD155. (c) The difference of Ki-67 expression between patients with low expression and overexpression of CD155.
(a)
(b)
(c)